In last trading session, Aspire Biopharma Holdings Inc (NASDAQ:ASBP) saw 3.18 million shares changing hands with its beta currently measuring 0.77. Company’s recent per share price level of $0.24 trading at -$0.09 or -26.90% at ring of the bell on the day assigns it a market valuation of $11.62M. That closing price of ASBP’s stock is at a discount of -6483.33% from its 52-week high price of $15.80 and is indicating a discount of -25.0% from its 52-week low price of $0.30. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.61 million shares which gives us an average trading volume of 574.90K if we extend that period to 3-months.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information

Upright in the red during last session for losing -26.90%, in the last five days ASBP remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $0.24 price level, adding 42.69% to its value on the day. Aspire Biopharma Holdings Inc’s shares saw a change of -97.93% in year-to-date performance and have moved -27.32% in past 5-day. Aspire Biopharma Holdings Inc (NASDAQ:ASBP) showed a performance of -61.65% in past 30-days. Number of shares sold short was 98369.0 shares which calculate 0.51 days to cover the short interests.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders

Insiders are in possession of 36.90% of company’s total shares while institution are holding 2.35 percent of that, with stock having share float percentage of 3.73%. Investors also watch the number of corporate investors in a company very closely, which is 2.35% institutions for Aspire Biopharma Holdings Inc that are currently holding shares of the company.